Perampanel
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Perampanel and local guidelines before prescribing.
Anticonvulsant
Mechanism
AMPA receptor antagonist.
Uses
Focal seizures, generalised tonic-clonic seizures (adjunct).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Aggression, irritability, dizziness, weight gain.
Interactions
Enzyme inducers reduce levels.
Contraindications and cautions
Psychiatric disease caution
Monitoring
Mood
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
Take at night; monitor mood and behaviour.
More from the textbook: uses, cautions and other points
- Glutamate | Main excitatory transmitter; learning and memory (NMDA and AMPA receptors) | Excitotoxic cell death in stroke and trauma; memantine and ketamine block NMDA; perampanel blocks AMPA; riluzole reduces release (MND)
Neurology: Anatomy, Physiology and Pharmacology - How they work - block sodium channels (carbamazepine, lamotrigine, phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, …
Neurology: Anatomy, Physiology and Pharmacology - Perampanel - aggression, hostility, mood change.
Neurology: Anatomy, Physiology and Pharmacology - Newer drugs (e.g. cenobamate , perampanel, brivaracetam; cannabidiol and fenfluramine for specific syndromes).
Neurology: Epilepsy
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Epilepsy (1 mention)